Get the latest Science News and Discoveries
Domain-alteration chimeras rewire oncogenic complexes in prostate cancer
A novel therapeutic modality enforces non-native androgen receptor (AR)–p300/CBP interactions to collapse AR transcriptional programs, producing super-inhibitory, lineage-selective suppression of metastatic prostate cancer and establishing domain-alteration chimeras as a broadly applicable therapeutic strategy leveraging induced proximity.
None
Or read this on Nature
